다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Alzheimer disease and associated disorders, v.29 no.1, 2015년, pp.1 - 5
Liang, Li (*Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA †Department of Medicinal Chemistry, School of Pharmacy, The Fourth Military Medical School, Xi’an, Shaanxi, China) , Wei, Huafeng
Alzheimer disease (AD) is a fatal progressive disease and the most common form of dementia without effective treatments. Previous studies support that the disruption of endoplasmic reticulum Ca through overactivation of ryanodine receptors plays an important role in the pathogenesis of AD. Normalization of intracellular Ca homeostasis could be an effective strategy for AD therapies. Dantrolene, an antagonist of ryanodine receptors and an FDA-approved drug for clinical treatment of malignant hyperthermia and muscle spasms, exhibits neuroprotective effects in multiple models of neurodegenerative disorders. Recent preclinical studies consistently support the therapeutic effects of dantrolene in various types of AD animal models and were summarized in the current review.
Biomed Res Int Ridge 2013 254954 2013 10.1155/2013/254954 Genetics of Alzheimers disease.
Nat Rev Neurol Wang 10 188 2014 10.1038/nrneurol.2014.44 Alzheimer disease: lessons from immunotherapy for Alzheimer disease.
Biochem Pharmacol Reitz 88 640 2014 10.1016/j.bcp.2013.12.024 Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.
Nat Rev Neurol Bible 10 125 2014 10.1038/nrneurol.2014.25 Alzheimer disease: high serum levels of the pesticide metabolite DDEa potential environmental risk factor for Alzheimer disease.
PLoS One Yang 9 e99171 2014 10.1371/journal.pone.0099171 . Comparison of neurodegeneration and cognitive impairment in neonatal mice exposed to propofol or isoflurane.
Anesthesiology Joseph 121 528 2014 10.1097/ALN.0000000000000316 . General anesthetic isoflurane modulates inositol 1, 4, 5-trisphosphate receptor calcium channel opening.
Eur J Neurosci Lelos 39 1690 2014 10.1111/ejn.12527 Beta-amyloid pathology alters neural network activation during retrieval of contextual fear memories in a mouse model of Alzheimers disease.
Neurodegener Dis Small 13 96 2014 10.1159/000353686 . Beta-amyloid precursor protein: function in stem cell development and Alzheimers disease brain.
Am J Geriatr Psychiatry Sultzer 22 1346 2013 10.1016/j.jagp.2013.06.005 . Neurobiology of delusions, memory, and insight in Alzheimer disease.
Skaper 12 445 2013 A Toll road to Alzheimer diseaseCNS Neurol Disord Drug Targets.
J Am Med Dir Assoc Shah 14 398 2013 10.1016/j.jamda.2013.01.014 The role of nutrition and diet in Alzheimer disease: a systematic review.
Int J Neuropsychopharmacol Lane 9 101 2006 10.1017/S1461145705005833 Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
Curr Top Med Chem Catalano 6 597 2006 10.2174/156802606776743066 . The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimers disease.
Int J Biochem Cell Biol Pimplikar 41 1261 2009 10.1016/j.biocel.2008.12.015 Reassessing the amyloid cascade hypothesis of Alzheimers disease.
J Alzheimers Dis Taher 38 831 2014 10.3233/JAD-131061 . Amyloid-beta alters the DNA methylation status of cell-fate genes in an Alzheimers disease model.
J Alzheimers Dis Portelius 31 335 2012 10.3233/JAD-2012-120508 . Amyloid-beta(1-1516) as a marker for gamma-secretase inhibition in Alzheimers disease.
Science Hardy 297 353 2002 10.1126/science.1072994 The amyloid hypothesis of Alzheimers disease: progress and problems on the road to therapeutics.
J Am Chem Soc Folk 132 4994 2010 10.1021/ja100943r A prochelator activated by beta-secretase inhibits Abeta aggregation and suppresses copper-induced reactive oxygen species formation.
Acta Neuropathol Boche 120 369 2010 10.1007/s00401-010-0719-5 . Neuropathology after active Abeta42 immunotherapy: implications for Alzheimers disease pathogenesis.
Nat Rev Neurol Giacobini 9 677 2013 10.1038/nrneurol.2013.223 Alzheimer disease therapymoving from amyloid-beta to tau.
Alzheimers Dement Drachman 10 372 2014 10.1016/j.jalz.2013.11.003 The amyloid hypothesis, time to move on: amyloid is the downstream result, not cause, of Alzheimers disease.
Biochem Pharmacol Iqbal 88 631 2014 10.1016/j.bcp.2014.01.002 Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles.
Expert Rev Clin Immunol Panza 10 405 2014 10.1586/1744666X.2014.883921 . Amyloid-based immunotherapy for Alzheimers disease in the time of prevention trials: the way forward.
Nat Rev Drug Discov Karran 10 698 2011 10.1038/nrd3505 The amyloid cascade hypothesis for Alzheimers disease: an appraisal for the development of therapeutics.
Neurobiol Aging Rosenblum 35 969 2014 10.1016/j.neurobiolaging.2013.10.085 Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult.
Is there still any hope for amyloid-based immunotherapy for Alzheimers diseaseCurr Opin Psychiatry Panza 27 128 2014 Imbimbo BP, et al..
Tiiman 62 367 2013 The missing link in the amyloid cascade of Alzheimers diseasemetal ionsNeurochem Int.
Biochim Biophys Acta Swerdlow 1842 1219 2013 10.1016/j.bbadis.2013.09.010 The Alzheimers disease mitochondrial cascade hypothesis: progress and perspectives.
Acta Neuropathol McGeer 126 479 2013 10.1007/s00401-013-1177-7 The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.
Clin Neurosci Schousboe 4 194 1997 Role of Ca2 and other second messengers in excitatory amino acid receptor mediated neurodegeneration: clinical perspectives.
Pflugers Arch Berridge 459 441 2010 10.1007/s00424-009-0736-1 Calcium hypothesis of Alzheimers disease.
Cell Calcium Wallace 55 175 2014 10.1016/j.ceca.2014.02.005 Calcium dysregulation, and lithium treatment to forestall Alzheimers diseasea merging of hypotheses.
Rev Neurosci Saravanaraman 25 231 2014 10.1515/revneuro-2013-0056 Why calcium channel blockers could be an elite choice in the treatment of Alzheimers disease: a comprehensive review of evidences.
J Physiol Berridge 592 pt 2 281 2014 10.1113/jphysiol.2013.257527 Calcium regulation of neural rhythms, memory and Alzheimers disease.
J Biol Chem Zeiger 288 26955 2013 10.1074/jbc.M113.473355 . Ca2 influx through store-operated Ca2 channels reduces Alzheimer disease beta-amyloid peptide secretion.
Front Mol Neurosci Popugaeva 6 29 2013 10.3389/fnmol.2013.00029 Role of endoplasmic reticulum Ca2 signaling in the pathogenesis of Alzheimer disease.
Usp Fiziol Nauk Riazantseva 43 59 2012 Calcium hypothesis of Alzheimer disease.
Mol Cell Neurosci Schon 55 26 2013 10.1016/j.mcn.2012.07.011 Mitochondria-associated ER membranes in Alzheimer disease.
Neurobiol Aging Du 32 398 2011 10.1016/j.neurobiolaging.2009.03.003 . Cyclophilin D deficiency improves mitochondrial function and learningmemory in aging Alzheimer disease mouse model.
Biochim Biophys Acta Anekonda 1812 1584 2011 10.1016/j.bbadis.2011.08.013 Calcium channel blocking as a therapeutic strategy for Alzheimers disease: the case for isradipine.
Proc Natl Acad Sci U S A Diaz 106 3348 2009 10.1073/pnas.0813355106 . Small molecule blockers of the Alzheimer Abeta calcium channel potently protect neurons from Abeta cytotoxicity.
Neurobiol Aging Yasar 26 157 2005 10.1016/j.neurobiolaging.2004.03.009 . Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging.
Cell Calcium Supnet 47 183 2010 10.1016/j.ceca.2009.12.014 The dysregulation of intracellular calcium in Alzheimer disease.
Am J Med Genet B Neuropsychiatr Genet Conley 150B 703 2009 10.1002/ajmg.b.30896 . Evidence supporting a role for the calcium-sensing receptor in Alzheimer disease.
Popugaeva 13 139 2014 Can the calcium hypothesis explain synaptic loss in Alzheimers diseaseNeurodegener Dis.
Cell Calcium Supnet 50 303 2011 10.1016/j.ceca.2011.05.013 Presenilins function in ER calcium leak and Alzheimers disease pathogenesis.
Mol Neurodegener Chen 6 81 2011 10.1186/1750-1326-6-81 . Dantrolene is neuroprotective in Huntingtons disease transgenic mouse model.
Neurobiol Aging Khachaturian 8 345 1987 10.1016/0197-4580(87)90073-X Hypothesis on the regulation of cytosol calcium concentration and the aging brain.
Sci China Life Sci Supnet 54 744 2011 10.1007/s11427-011-4201-y Presenilins as endoplasmic reticulum calcium leak channels and Alzheimers disease pathogenesis.
Acta Naturae Bezprozvanny 2 72 2010 10.32607/20758251-2010-2-1-72-80 Calcium signaling and neurodegeneration.
Rev Neurosci Nimmrich 20 1 2009 10.1515/REVNEURO.2009.20.1.1 Is Alzheimers disease a result of presynaptic failure Synaptic dysfunctions induced by oligomeric beta-amyloid.
J Pineal Res Rosales-Corral 52 167 2012 10.1111/j.1600-079X.2011.00937.x . Alzheimers disease: pathological mechanisms and the beneficial role of melatonin.
ACS Chem Neurosci Fernandez-Morales 3 873 2012 10.1021/cn3001069 . Stabilizers of neuronal and mitochondrial calcium cycling as a strategy for developing a medicine for Alzheimers disease.
Neurochem Res Berridge 36 1149 2011 10.1007/s11064-010-0371-4 Calcium signalling and Alzheimers disease.
Trends Neurosci Verkhratsky 21 2 1998 10.1016/S0166-2236(97)01156-9 Calcium and neuronal ageing.
J Neurochem Mattson 70 1 1998 10.1046/j.1471-4159.1998.70010001.x . Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimers disease.
Khachaturian 46 78 1991 Calcium and the aging brain: upsetting a delicate balanceGeriatrics.
Mol Cell Biol Mattson 1 120 2000 Apoptosis in neurodegenerative disorders. Nature reviews.
J Leukoc Biol Misra 70 677 2001 10.1189/jlb.70.4.677 . Apolipoprotein E and mimetic peptide initiate a calcium-dependent signaling response in macrophages.
J Neurovirol Mattson 8 539 2002 10.1080/13550280290100978 Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimers disease.
Rev Neurosci Bordji 22 285 2011 10.1515/rns.2011.029 Synapses, NMDA receptor activity and neuronal Abeta production in Alzheimers disease.
Trends Pharmacol Sci Bardo 27 78 2006 10.1016/j.tips.2005.12.008 The role of the endoplasmic reticulum Ca2 store in the plasticity of central neurons.
J Neurosci Goussakov 30 12128 2010 10.1523/JNEUROSCI.2474-10.2010 NMDA-mediated Ca(2) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimers disease mice.
J Biol Chem Demuro 285 12463 2010 10.1074/jbc.R109.080895 Calcium signaling and amyloid toxicity in Alzheimer disease.
Front Mol Neurosci Jensen 6 36 2013 10.3389/fnmol.2013.00036 . Alzheimers disease-associated peptide Abeta42 mobilizes ER Ca(2) via InsP3R-dependent and -independent mechanisms.
J Neuroinflammation Salminen 6 41 2009 10.1186/1742-2094-6-41 . ER stress in Alzheimers disease: a novel neuronal trigger for inflammation and Alzheimers pathology.
FEBS J Seo 280 6691 2013 10.1111/febs.12572 . Trichostatin A epigenetically increases calpastatin expression and inhibits calpain activity and calcium-induced SH-SY5Y neuronal cell toxicity.
J Alzheimers Dis Daschil 37 439 2013 10.3233/JAD-130560 . CaV1.2 calcium channel expression in reactive astrocytes is associated with the formation of amyloid-beta plaques in an Alzheimers disease mouse model.
Eur J Pharmacol Chakroborty 739 83 2013 10.1016/j.ejphar.2013.11.012 Calcium channelopathies and Alzheimers disease: Insight into therapeutic success and failures.
J Neurosci Chakroborty 32 8341 2012 10.1523/JNEUROSCI.0936-12.2012 . Early presynaptic and postsynaptic calcium signaling abnormalities mask underlying synaptic depression in presymptomatic Alzheimers disease mice.
J Neurosci Stutzmann 26 5180 2006 10.1523/JNEUROSCI.0739-06.2006 . Enhanced ryanodine receptor recruitment contributes to Ca2 disruptions in young, adult, and aged Alzheimers disease mice.
Stutzmann 11 110 2005 Calcium dysregulation, IP3 signaling, and Alzheimers diseaseNeuroscientist.
J Vet Sci Ahn 2 131 2001 10.4142/jvs.2001.2.2.131 Effect of IP3 and ryanodine treatments on the development of bovine parthenogenetic and reconstructed embryos.
Int J Alzheimers Dis Rodriguez 2014 180741 2014 . Spectral analysis of EEG in familial Alzheimers disease with E280A presenilin-1 mutation gene.
J Alzheimers Dis Larner 37 653 2013 10.3233/JAD-130746 Presenilin-1 mutations in Alzheimers disease: an update on genotype-phenotype relationships.
Adv Exp Med Biol Lanner 740 217 2012 10.1007/978-94-007-2888-2_9 Ryanodine receptor physiology and its role in disease.
Ann N Y Acad Sci Stutzmann 1097 265 2007 10.1196/annals.1379.025 . Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimers mouse models.
J Neurosci Chakroborty 29 9458 2009 10.1523/JNEUROSCI.2047-09.2009 . Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice.
Cell Calcium Hayrapetyan 44 507 2008 10.1016/j.ceca.2008.03.004 . The N-terminus of presenilin-2 increases single channel activity of brain ryanodine receptors through direct protein-protein interaction.
Circ Res Hwang 114 1114 2014 10.1161/CIRCRESAHA.114.303391 . Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants.
Hum Genet Koran 133 85 2014 10.1007/s00439-013-1354-8 Genetic interactions found between calcium channel genes modulate amyloid load measured by positron emission tomography.
Int J Biochem Cell Biol Honarnejad 44 1983 2012 10.1016/j.biocel.2012.07.019 Presenilins: role in calcium homeostasis.
Toxicol In Vitro Fan 27 387 2013 10.1016/j.tiv.2012.06.019 . Lead-induced ER calcium release and inhibitory effects of methionine choline in cultured rat hippocampal neurons.
Channels Goussakov 5 9 2011 10.4161/chan.5.1.14124 Generation of dendritic Ca2 oscillations as a consequence of altered ryanodine receptor function in AD neurons.
J Cardiovasc Electrophysiol Chou 25 431 2014 10.1111/jce.12320 . Dantrolene suppresses ventricular ectopy and arrhythmogenicity with acute myocardial infarction in a langendorff-perfused pacing-induced heart failure rabbit model.
Biomed Res Int Bannister 2013 390493 2013 10.1155/2013/390493 Dantrolene-induced inhibition of skeletal L-type Ca2 current requires RyR1 expression.
Neuroscience Staats 220 26 2012 10.1016/j.neuroscience.2012.06.050 . Dantrolene is neuroprotective in vitro, but does not affect survival in SOD1(G(9)(3)A) mice.
Eur J Anaesthesiol Ginz 29 161 2012 10.1097/EJA.0b013e32834c7c9d . Dantrolene for severe rhabdomyolysis in Staphylococcus aureus toxic shock syndrome.
Neurochem Int Makarewicz 43 273 2003 10.1016/S0197-0186(03)00012-3 Dantrolene inhibits NMDA-induced 45Ca uptake in cultured cerebellar granule neurons.
J Neurosci Mattson 20 1358 2000 10.1523/JNEUROSCI.20-04-01358.2000 . Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis.
J Neurosci Liu 29 9148 2009 10.1523/JNEUROSCI.0660-09.2009 . Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2.
Neurosci Lett Peng 516 274 2012 10.1016/j.neulet.2012.04.008 . Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice.
J Neurosci Oules 32 11820 2014 10.1523/JNEUROSCI.0875-12.2012 . Ryanodine receptor blockade reduces amyloid-beta load and memory impairments in Tg2576 mouse model of Alzheimer disease.
PLoS One Chakroborty 7 e52056 2012 10.1371/journal.pone.0052056 . Stabilizing ER Ca2 channel function as an early preventative strategy for Alzheimers disease.
J Neurosci Zhang 30 8566 2010 10.1523/JNEUROSCI.1554-10.2010 . Role of presenilins in neuronal calcium homeostasis.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.